Skip to content

13F-HR filed by ABG-WTT Global Life Science Capital Partners GP Ltd

ABG-WTT Global Life Science Capital Partners GP Ltd filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-14, with 3 holding rows worth $20,119,370.

Accession
0000950123-24-011466
Filed
2024-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2024

A holdings report, 3 entries on the cover page, a total value of $20,119,370 stated on the cover page (in dollars after the unit check, H1), rows summing to $20,119,370 with VALUE read as dollars as filed, 13F file number 028-20836. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CG ONCOLOGY INC156944100COMMON STOCK495,526$18,696,196dollars as filed
RAPID MICRO BIOSYSTEMS INC75340L104CLASS A COM1,038,296$924,083dollars as filed
PULMONX CORP745848101COM60,204$499,091dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-24-011466this filing2024-11-14acceptance time not in the bulk data set